Clinical Trials Browser

Phase 2 × Completed × drozitumab × Clear all

NCT00517049 2017-06-06

A Study of PRO95780 in Combination With Rituximab in Patients With Non-Hodgkin's Lymphoma That Has Progressed Following Previous Rituximab Therapy (APM4083g)

Phase 2 Completed

Lymphoma, Lymphoma, Non-Hodgkin

NCT00480831 2017-05-18

A Study of PRO95780 in Patients With Previously Untreated, Advanced-Stage Non-Small Cell Lung Cancer (APM4074g)

Phase 2 Completed

Carcinoma, Non-Small-Cell Lung, Neoplasms